EuropaBio appoints new Chair, Vice-Chairs and welcomes eleven new members
At its Annual General Assembly, held in Brussels on June 26th, EuropaBio formally appointed André Goig, Regional Director EAME (Europe, Middle East and Africa) Syngenta AG, as Chair of the Association. He succeeds Stephan Tanda, who has completed his mandate and will continue to represent Royal DSM in his new function as Chair of the Industrial Biotechnology Council and one of the Vice Chairs of EuropaBio.
The General Assembly also confirmed the appointment of the other Vice-Chairs of the association with Emmanuel Chantelot, Shire, as Chair of the Healthcare Biotechnology Council; Ricardo Gent, DIB-The German Biotechnology Association, as Chair of the National Associations Council and Tom Saylor, Arecor Ltd, as Chair of the SME Platform. André Goig, will also remain Chair of the Agriculture Biotechnology Council ad interim for a year.
The association also elected four new corporate board members, bringing the number of representatives of companies and associations from across Europe to 26 on the EuropaBio Board.
In addition to these appointments, 11 new corporate and associate members were approved by the General Assembly. These are: Biogen Idec; Raptor Pharmaceuticals Corp; Sanofi Pasteur MSD; TWB Toulouse; Vito; Vitromics Healthcare Holding; Protaffin Biotechnology AG and Global Bioenergies SA as corporate members and Deerfield Management Company, iQX; Maxhill Publishers LTD as associate members.
Commenting on his appointment, André Goig said: “Having represented Syngenta on the EuropaBio board for a number of years, and having held the position of Vice Chair of the association in my role as Agri-Food Council Chair, I relish the new challenges that lie ahead as Chair of the association. EuropaBio members are a key driving force behind the European innovation agenda, and I firmly believe that biotechnology is uniquely positioned to bring solutions to the Grand Challenges we face today, of healing, feeding and fuelling an increasing population. I look forward to working closely with EuropaBio members and staff in bringing our industry, and the benefits that it offers, to the attention of European policy makers and the wider public.”
In welcoming the new appointments and members, Nathalie Moll, Secretary General of EuropaBio stated: “We are delighted to welcome our new Chairman, Vice Chairs and Board members and are grateful for their dedication to our association and our common mission. Moreover, it is particularly telling to see that there are eleven new members joining EuropaBio this year, highlighting the ever increasing commitment of biotech companies and their service providers to promoting an innovative and dynamic biotechnology-based industry in Europe.”
See more at: http://www.europabio.org/